SCHEMBL5536768

SCHEMBL5536768

NS(=O)(=O)Nc1ccc(-c2ccc(S(=O)(=O)C(F)(F)F)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 9/20 0.71
CA2 P00918 11/20 0.56
CA1 P00915 10/20 0.56
CA12 O43570 2/20 0.56
CA9 Q16790 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766565 0.83 KIF11 (1.00) KIF11CA2CA1CA12CA9
SCHEMBL5531754 0.79 KIF11 (1.00) KIF11CA2CA1
SCHEMBL5434550 0.77 KIF11 (1.00) KIF11CA2CA1CA12CA9
SCHEMBL5431851 0.76 KIF11 (0.61) KIF11CA2CA1
SCHEMBL9703315 0.76 CA2 (0.57) KIF11CA2CA1CA12CA9
SCHEMBL3910315 0.76 CA12 (0.57) KIF11CA2CA1CA12CA9
SCHEMBL5527222 0.76 KIF11 (0.59) KIF11CA2CA1CA12CA9
SCHEMBL28217808 0.74 KIF11 (0.58) KIF11CA2CA1CA12CA9
SCHEMBL6849852 0.73 CA2 (0.57) KIF11CA2CA1CA12CA9
SCHEMBL28472964 0.73 CA2 (1.00) CA2CA1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142460-A1 Compounds, compositions and methods CYTOKINETICS, INCORPORATED 2007-06-21 US claimed
US-20070142460-A1 Compounds, compositions and methods CYTOKINETICS, INCORPORATED 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142460-A1 Compounds, compositions and methods ALPP, PCNA, MKI67 KIF11 824/4885CA2 2768/4885CA1 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.